• Introduction to 340B Program and Rx Manufacturer Patient Assistance Programs
• Understanding how Medicare Part D and the 340B drug discount programs intersect
• Helping beneficiaries with "extra help":  strategies for maximizing enrollment in the Part D low-income subsidy 
• New opportunities for Medicare reimbursement
• Reconciling formulary differences between Part D plans and 340B providers
• A new duplicate discount quandary:  Should 340B prescriptions be excluded from private rebate negotiations between Part D plans and manufacturers?
• TrOOPing through the doughnut hole:  what counts, what doesn't, and why it matters in reaching Part D catastrophic coverage
• Special problems of dual eligibles:  when auto-enrollment leads to a poor plan choice
• Issues that manufacturers, health plans and providers face in promoting their products and services in this new environment
• Wisdom at the window:  how providers can give meaningful Part D advice without illegally steering beneficiaries
• Co-branding and other partnership models for pharmacies and PDPs
• Billing and coverage issues for transplant and cancer patients:  when to bill what to Medicare Part B and Part D and what Medicaid will continue to cover
• Patient Assistance Programs in the new world of Medicare Part D:  will Medicare beneficiaries be excluded from PAPs?   
• Independent foundation-model PAPs:  how to structure an OIG-compliant PAP and still provide access to needy patients
• State Pharmacy Assistance Program expansions: how states are using SPAPs to wrap-around Medicare Part D and the impact on covered entities

• Vicki Robinson, Chief, Industry Guidance Branch,  HHS Office of Inspector General  (The government's lead official on compliance issues related to Patient Assistance Programs)
• Vanessa Duran, Senior Policy Analyst, Division of Drug Plan Policy, Medicare Plan Policy Group, Centers for Medicare and Medicaid Services (Key point person on Part D network contracting and benefit design issues)
• Scott Hughes, Vice President, MemberHealth, Community Care Rx Card
• Tracy Sims, Manager, Strategic Marketing, U.S. Business to Business, Eli Lilly & Company
• Marcus Farbstein, Government Accounts Manager, Genentech
• Michael Sullivan, Health Insurance Specialist, Centers for Medicare & Medicaid Services
• Jim Mitchell, Director, Office of Pharmacy Affairs
• Bill von Oehsen, General Counsel, Public Hospital Pharmacy Coalition
• Chris Hatwig, Senior Director, 340B Prime Vendor Program
• Freda Mitchem, Director of Systems Development and Policy Administration, National Association of Community Health Centers
• Diane Goyette, Senior Director, Pharmacy Services Support Center

View Preliminary Agenda